PROLOCK Trademark

Trademark Overview

On Friday, November 15, 2019, a trademark application was filed for PROLOCK with the United States Patent and Trademark Office. The USPTO has given the PROLOCK trademark a serial number of 88693687. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 4, 2023. This trademark is owned by Fog Pharmaceuticals, Inc.. The PROLOCK trademark is filed in the Pharmaceutical Products category with the following description:

biomedical compounds for medical purposes, namely, amino acids, peptides, stapled peptides, and synthetic peptides, in particular amino acids for the medical treatment of cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions; biomedical compounds for medical purposes, namely, miniproteins and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions
prolock

General Information

Serial Number88693687
Word MarkPROLOCK
Filing DateFriday, November 15, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 4, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements

Goods and Servicesbiomedical compounds for medical purposes, namely, amino acids, peptides, stapled peptides, and synthetic peptides, in particular amino acids for the medical treatment of cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions; biomedical compounds for medical purposes, namely, miniproteins and cell-penetrating miniproteins (CPMPs) arrays for diagnosing cancer, inflammatory conditions, immunological disorders, cardiovascular conditions, infectious diseases, and neurological conditions
Pseudo MarkPRO LOCK

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 21, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePARABILIS MEDICINES, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02140
Party NameFog Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140
Party NameFog Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events

Event DateEvent Description
Tuesday, November 19, 2019NEW APPLICATION ENTERED
Thursday, November 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 10, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 19, 2020ASSIGNED TO EXAMINER
Thursday, February 20, 2020NON-FINAL ACTION WRITTEN
Thursday, February 20, 2020NON-FINAL ACTION E-MAILED
Thursday, February 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, April 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 31, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 31, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 1, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 3, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 22, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 22, 2021SOU EXTENSION 1 FILED
Thursday, April 22, 2021SOU EXTENSION 1 GRANTED
Saturday, April 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 15, 2021SOU TEAS EXTENSION RECEIVED
Friday, October 15, 2021SOU EXTENSION 2 FILED
Friday, October 15, 2021SOU EXTENSION 2 GRANTED
Tuesday, October 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 25, 2022SOU TEAS EXTENSION RECEIVED
Monday, April 25, 2022SOU EXTENSION 3 FILED
Monday, April 25, 2022SOU EXTENSION 3 GRANTED
Wednesday, April 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 5, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, October 5, 2022SOU EXTENSION 4 FILED
Wednesday, October 5, 2022SOU EXTENSION 4 GRANTED
Friday, October 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 13, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 13, 2023SOU EXTENSION 5 FILED
Wednesday, April 19, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 19, 2023SOU EXTENSION 5 GRANTED
Thursday, April 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 4, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, December 4, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, November 6, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

prolock conditions peptides medical disorders immunological biomedical infectious miniproteins neurological diseases